BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3979487)

  • 21. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.
    Augarten A; Ben Tov A; Madgar I; Barak A; Akons H; Laufer J; Efrati O; Aviram M; Bentur L; Blau H; Paret G; Wilschanski M; Kerem BS; Yahav Y
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):164-8. PubMed ID: 18301294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. X-ray microanalysis of the fingernails of uremic patients treated by hemodialysis.
    Zevin D; Weinstein T; Levi J; Djaldetti M
    Clin Nephrol; 1991 Dec; 36(6):302-4. PubMed ID: 1769143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sweat electrolyte and cystic fibrosis mutation analysis allows early diagnosis in Brazilian children with clinical signs compatible with cystic fibrosis.
    Rabbi-Bortolini E; Bernardino AL; Lopes AL; Ferri AS; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Apr; 76(4):288-90. PubMed ID: 9545091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conductivity determined by a new sweat analyzer compared with chloride concentrations for the diagnosis of cystic fibrosis.
    Barben J; Ammann RA; Metlagel A; Schoeni MH;
    J Pediatr; 2005 Feb; 146(2):183-8. PubMed ID: 15689903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aquagenic wrinkling of the palms in cystic fibrosis: comparison with controls and genotype-phenotype correlations.
    Berk DR; Ciliberto HM; Sweet SC; Ferkol TW; Bayliss SJ
    Arch Dermatol; 2009 Nov; 145(11):1296-9. PubMed ID: 19917960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New diagnostic method for cystic fibrosis.
    Taylor CJ; Baxter PS; Dickson J; Hardcastle J; Hardcastle PT; Goldhill J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):142-3. PubMed ID: 2130677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of dental status and oral hygiene in the study population of cystic fibrosis patients in the Podlasie province.
    Dabrowska E; Błahuszewska K; Minarowska A; Kaczmarski M; Niedźwiecka-Andrzejewicz I; Stokowska W
    Adv Med Sci; 2006; 51 Suppl 1():100-3. PubMed ID: 17458069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum zinc concentrations in cystic fibrosis patients aged above 4 years: a cross-sectional evaluation.
    Van Biervliet S; Van Biervliet JP; Vande Velde S; Robberecht E
    Biol Trace Elem Res; 2007 Oct; 119(1):19-26. PubMed ID: 17914215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients.
    Van Biervliet S; Vanbillemont G; Van Biervliet JP; Declercq D; Robberecht E; Christophe A
    Ann Nutr Metab; 2007; 51(6):541-9. PubMed ID: 18227622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cystic fibrosis - ultrastructural and microanalytical studies.
    Roomans GM; von Euler AM; Müller RM
    Scan Electron Microsc; 1983; (Pt 2):697-712. PubMed ID: 6356334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics of ciprofloxacin in pediatric patients.
    Rajagopalan P; Gastonguay MR
    J Clin Pharmacol; 2003 Jul; 43(7):698-710. PubMed ID: 12856383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case report of cystic fibrosis and review of 16 cases of cystic fibrosis in Chinese patients].
    Li N; He B; Wang GF; Tang XY
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Sep; 26(9):559-62. PubMed ID: 14521762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different glycosylation of human prolactin in cystic fibrosis patients.
    Robertson MT; Boyajian MJ; Kulczycki LL; Martin AL
    Acta Univ Carol Med (Praha); 1990; 36(1-4):49-54. PubMed ID: 2130718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on the sodium and potassium content in finger and toenails. A new method for the diagnosis of mucoviscidosis (cystic fibrosis)].
    Grosse KP; Stephan U; Sitzmann FC
    Z Kinderheilkd; 1967; 100(2):87-100. PubMed ID: 5594145
    [No Abstract]   [Full Text] [Related]  

  • 36. Neutron activation analysis technique for nail sodium concentration in cystic fibrosis patients.
    Johnson GF; Thompson MF; Fetteroff S; Fasano AN
    Pediatrics; 1971 Jan; 47(1):88-93. PubMed ID: 5545408
    [No Abstract]   [Full Text] [Related]  

  • 37. [Risk of urolithiasis in patients with cystic fibrosis].
    Campuzano S; Díaz JJ; Bousoño C; Rodríguez M; Campos C; Málaga S
    Nefrologia; 2009; 29(1):61-6. PubMed ID: 19240773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for cystic fibrosis with chloride electrode. An investigation of sweat chloride with chloride electrode orion 417 in normal persons and in patients with cystic fibrosis.
    Steinrud J; Winkel S; Flensborg EW
    Dan Med Bull; 1974 Oct; 21(6):251-5. PubMed ID: 4430191
    [No Abstract]   [Full Text] [Related]  

  • 39. A clinical study of the diagnosis of cystic fibrosis by instrumental neutron activation analysis of sodium in nail clippings.
    Kollberg H; Ekbohm G
    Acta Paediatr Scand; 1974 May; 63(3):411-7. PubMed ID: 4838970
    [No Abstract]   [Full Text] [Related]  

  • 40. [Sodium determination in nails of healthy children and children with mucoviscidosis by means of the neutron activation analysis method].
    Duchnowska A; Nowakowska A; Kania B; Werys R; Zebrak J
    Pediatr Pol; 1975 Aug; 50(8):963-9. PubMed ID: 1161357
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.